NeuroPace (NPCE) Change in Account Payables (2020 - 2026)
NeuroPace's quarterly Change in Account Payables came in at $2.2 million in Q1 2026, up 127.23% year-on-year from $966000.0 in Q1 2025, and up 192.03% quarter-over-quarter from -$2.4 million in Q4 2025.
NeuroPace has reported Change in Account Payables for 7 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 127.23% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $499000.0 (down 27.37% YoY), and the FY2025 full-year result was -$730000.0, down 208.79% from the prior year.
- Change in Account Payables for Q1 2026 stood at $2.2 million, up from -$2.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $2.2 million in Q1 2026, with the low at -$2.4 million in Q4 2025.
- Average Change in Account Payables over 5 years is $177823.5, with a median of -$22000.0 recorded in 2023.
- Peak annual rise in Change in Account Payables reached 592.23% in 2024, while the deepest fall reached 4090.91% in 2024.
- Tracing NPCE's Change in Account Payables over 5 years: stood at $855000.0 in 2022, then grew by 23.39% to $1.1 million in 2023, then decreased by 26.73% to $773000.0 in 2024, then plunged by 408.54% to -$2.4 million in 2025, then soared by 192.03% to $2.2 million in 2026.
- The last three Change in Account Payables figures came in at $2.2 million (Q1 2026), -$2.4 million (Q4 2025), and -$48000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -48,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | -600,000.00 |
| Sep 30, 2023 | -600,000.00 |
| Jun 30, 2023 | -22,000.00 |
| Jun 30, 2023 | -22,000.00 |
| Mar 31, 2023 | -193,000.00 |
| Mar 31, 2023 | -193,000.00 |
| Dec 31, 2022 | 855,000.00 |
| Dec 31, 2022 | 855,000.00 |
| Sep 30, 2022 | -301,000.00 |
| Sep 30, 2022 | -301,000.00 |
| Jun 30, 2022 | -727,000.00 |
| Jun 30, 2022 | -727,000.00 |
| Mar 31, 2022 | 820,000.00 |
| Mar 31, 2022 | 820,000.00 |
| Dec 31, 2021 | 220,000.00 |
| Dec 31, 2021 | 220,000.00 |
| Sep 30, 2021 | 191,000.00 |
| Sep 30, 2021 | 191,000.00 |
| Jun 30, 2021 | -468,000.00 |
| Jun 30, 2021 | -468,000.00 |
| Mar 31, 2021 | 536,000.00 |
| Mar 31, 2021 | 536,000.00 |
| Dec 31, 2020 | -50,000.00 |
| Dec 31, 2020 | -50,000.00 |
| Sep 30, 2020 | 463,000.00 |
| Sep 30, 2020 | 463,000.00 |
| Jun 30, 2020 | -309,000.00 |
| Jun 30, 2020 | -309,000.00 |
| Mar 31, 2020 | -109,000.00 |
| Mar 31, 2020 | -109,000.00 |